Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVANTAGE: Betaferon vs Rebif Injection Site Reactions in MS
NCT00317941Phase 4Completed
- Sponsor
- Bayer
- Start
- Mar 2006
- Primary completion
- Apr 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon beta-1b in relapsing-remitting multiple sclerosis (RRMS), clinically isolated syndrome (CIS), sponsored by Bayer. Started Mar 2006; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT00317941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317941.